Impact of immune checkpoint inhibitors as neoadjuvant/perioperative therapy for locally advanced resectable gastric/gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis
BackgroundImmune checkpoint inhibitor (ICI)-based neoadjuvant/perioperative strategies are expanding for locally advanced resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, but the evidence base differs substantially across strategies…